Gut Microbiota Analysis in Patients Undergoing Duodencephalopancreasectomy for Pancreatic Cancer

ConditionPancreatic Cancer, Adult

Trial statusRecruiting

Trial phaseNot applicable

Trial typeInterventional

Biological sexAll

Age18+

SponsorIRCCS Azienda Ospedaliero-Universitaria di Bologna

About this trial

Pancreatic head cancer represents one of the most frequent malignancies with an incidence of about 13500 new cases each year. The primary objective of the study is to test whether there are bacterial species associated with increased risk of complications in patients with peri-ampullary neoplasia undergoing DCP.

Eligibility criteria

Qualifiers

Age ≥18 years

Diagnosis of resectable pancreatic adenocarcinoma with indication for "upfront" surgical treatment

ASA (American Society of Anesthesiology) score < 4

Obtaining informed consent

Disqualifiers

None

Trial design

Treatments tested in this trial

Microbiota analysis

Treatment groups

30 Participants

are divided into 1 treatment group

Sponsors and collaborators

IRCCS Azienda Ospedaliero-Universitaria di Bologna

Lead sponsor

Source ClinicalTrials.gov